Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,325,336 papers from all fields of science
Search
Sign In
Create Free Account
TCF3/PBX1 Fusion Gene
Known as:
PBX1/E2A FUSION GENE
, E2A/PBX1 Fusion Gene
, TCF3-PBX1 Fusion Gene
Expand
A fusion gene that results from a chromosomal translocation t(1;19)(q23;p13) which fuses intron 13 of the TCF3 gene with exon 2 of the PBX1 gene…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
E2A-Pbx1 fusion protein
Transcriptional Activation
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Detection and analysis of tumour biomarkers to strengthen the diagnosis of acute and chronic leukaemias
R. Cerón-Maldonado
,
A. Martínez-Tovar
,
+8 authors
I. Olarte-Carrillo
2015
Corpus ID: 58818000
2015
2015
Abstract B07: Prevalence of the most common fusion gene transcripts in 1080 Egyptian pediatric acute lymphoblastic leukemia patients: Children Cancer Hospital Egypt (CCHE) experience.
D. Yassin
,
S. Soliman
,
+11 authors
A. El-Haddad
2015
Corpus ID: 76151175
Introduction: Childhood acute lymphoblastic leukemia (ALL) is a highly heterogeneous disease with distinct biological subgroups…
Expand
Review
2014
Review
2014
Novel mechanisms of transcriptional regulation by leukemia fusion proteins
C. Gow
2014
Corpus ID: 78789325
......................................................................................................................i PREFACE…
Expand
2013
2013
Characteristics of the four subtypes of myelodysplastic/myeloproliferative neoplasms
Huanling Wu
,
Shuquan Bian
,
+4 authors
Zhiming Lu
Experimental and Therapeutic Medicine
2013
Corpus ID: 15717217
The aim of the present study was to investigate the characteristics of the four subtypes of myelodysplastic/myeloproliferative…
Expand
2011
2011
Real-time qPCR for assessment of minimal residual disease in acute myeloid and lymphoid leukemia Metodă real-time qPCR pentru evaluarea bolii minime reziduale în leucemiile acute mieloide şi limfoide
D. Jardan
,
R. Tălmaci
,
+4 authors
C. Arion
2011
Corpus ID: 30641552
Evaluation of minimal residual disease is of major importance in the course of acute leukemia treatment. There are a number of…
Expand
Review
2009
Review
2009
[Acute T cells lymphoblastic leukemia with a t(1;19)(q23;p13) and E2A-PBX1 in an adult: one case report and literature review].
G. He
,
Xu-hui Zhang
,
+7 authors
Xiao-hui Hu
Zhonghua xue ye xue za zhi = Zhonghua xueyexue…
2009
Corpus ID: 32335360
OBJECTIVE To report a case of T cell acute lymphoblastic leukemia (ALL) with t(1;19)(q23;pl3) and E2A-PBX1 fusion gene, which is…
Expand
2008
2008
[Correlation of E2a-pbx1 expression level with clinical characteristics and early response to treatment in children with acute lymphoblastic leukemia].
Chao Gao
,
Zhigang Li
,
Wei Zhao
,
Min-Yuan Wu
Zhongguo shi yan xue ye xue za zhi
2008
Corpus ID: 22646103
This study purposed to investigate the correlation of expression level of e2a-pbx1 (immunoglobulin enhancer binding factor-Pre-B…
Expand
2008
2008
Comparison of the biology of Down syndrome (DS) acute lymphoblastic leukemia (ALL) and non-DS ALL: Children's Oncology Group (COG) study P9900
K. Maloney
,
W. Carroll
,
+7 authors
B. Camitta
2008
Corpus ID: 74158092
10003 Background: DS ALL is a heterogeneous disorder with inferior survival compared to non-DS. Controversy exists regarding the…
Expand
Highly Cited
2001
Highly Cited
2001
HoxB8 requires its Pbx-interaction motif to block differentiation of primary myeloid progenitors and of most cell line models of myeloid differentiation
P. Knoepfler
,
D. Sykes
,
M. Pasillas
,
M. Kamps
Oncogene
2001
Corpus ID: 1788645
HoxB8 was the first homeobox gene identified as a cause of leukemia. In murine WEHI3B acute myeloid leukemia (AML) cells…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE